1-Month DAPT in High-Bleeding Risk Noninferior for Ischemic Outcomes, Less Bleeding: MASTER-DAPT In HBR patients after DES-PCI, shorter 1-month DAPT showed noninferior NACE/MACCE rates with less major bleeds compared to 12-month DAPT October 06, 2021 Read More
FLOWER-MI: FFR Shows No Benefit over Angio for Complete Revasc in Multi-vessel STEMIs Findings say FFR-guided PCI not superior (or cost-effective) compared to angio-guided PCI, although experts warn results may not be conclusive July 21, 2021 Read More
'Next-Gen' ADAPTABLE Study Says Low-Dose Aspirin Equal to High-Dose for ASCVD Patients High-tech, low-cost study reflects real-world data and finds 81mg aspirin superior, although critics say high switching rate impacts reliability of findings July 05, 2021 Read More